Pages that link to "Q80284338"
Jump to navigation
Jump to search
The following pages link to High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor (Q80284338):
Displaying 50 items.
- Protective Effects of HDL Against Ischemia/Reperfusion Injury (Q26772786) (← links)
- HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications (Q26779667) (← links)
- Lysophospholipids and their receptors in the central nervous system (Q26859168) (← links)
- HDL and glucose metabolism: current evidence and therapeutic potential (Q26996502) (← links)
- Cardioprotective functions of HDLs (Q27000421) (← links)
- Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress (Q27001065) (← links)
- Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure (Q27315147) (← links)
- From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research" (Q28073354) (← links)
- Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients (Q28304115) (← links)
- Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury (Q28544407) (← links)
- Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury (Q30278837) (← links)
- Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury (Q30423883) (← links)
- International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature (Q30429523) (← links)
- Biological roles of lysophospholipid receptors revealed by genetic null mice: an update (Q30487082) (← links)
- S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species (Q33573630) (← links)
- The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion (Q33613072) (← links)
- Sphingosine kinase and sphingosine 1-phosphate in cardioprotection (Q33715344) (← links)
- Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization (Q33715382) (← links)
- High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate (Q33727619) (← links)
- Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis? (Q33753317) (← links)
- Sphingosine kinase 1 in cancer (Q33853998) (← links)
- Sphingolipids in obesity, type 2 diabetes, and metabolic disease (Q33880588) (← links)
- Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells (Q33904083) (← links)
- Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. (Q33995071) (← links)
- Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion (Q34113032) (← links)
- RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection (Q34215871) (← links)
- Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoprotein (Q34439003) (← links)
- Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury (Q34497101) (← links)
- High density lipoprotein: it's not just about lipid transport anymore (Q34565254) (← links)
- "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets (Q34593159) (← links)
- Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist (Q35019936) (← links)
- Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning (Q35025398) (← links)
- Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failure (Q35161660) (← links)
- The impact of bioactive lipids on cardiovascular development (Q35173287) (← links)
- Effects of lysophospholipids on tumor microenvironment (Q35603140) (← links)
- Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules (Q35684358) (← links)
- Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury (Q35715879) (← links)
- Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice. (Q35757527) (← links)
- Sources, metabolism, and regulation of circulating sphingosine-1-phosphate (Q35776618) (← links)
- Insights into the pharmacological relevance of lysophospholipid receptors (Q35853199) (← links)
- A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. (Q36011190) (← links)
- Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain (Q36147515) (← links)
- Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles (Q36415245) (← links)
- Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction (Q36522680) (← links)
- Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. (Q36575703) (← links)
- Lipid profile of patients with acute myocardial infarction and its correlation with systemic inflammation (Q36580816) (← links)
- HDL and its sphingosine-1-phosphate content in cardioprotection (Q36842504) (← links)
- Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload (Q36867184) (← links)
- High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway (Q36895483) (← links)
- Implication of sphingosin-1-phosphate in cardiovascular regulation (Q36898368) (← links)